ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹-446 Cr | ₹-649 Cr | ₹-688 Cr | ₹-893 Cr | ₹-751 Cr |
What is the latest Total Non-Current Liabilities ratio of ALKEM LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹-446 Cr |
| Mar2024 | ₹-649 Cr |
| Mar2023 | ₹-688 Cr |
| Mar2022 | ₹-893 Cr |
| Mar2021 | ₹-751 Cr |
How is Total Non-Current Liabilities of ALKEM LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-446 Cr | Negative | |
| Mar2024 | ₹-649 Cr | Negative | |
| Mar2023 | ₹-688 Cr | Negative | |
| Mar2022 | ₹-893 Cr | Negative | |
| Mar2021 | ₹-751 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹66,543.6 Cr | 2.5% | 4.6% | 15.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | 2.5% |
4.6% |
15.9% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses